Advertisement

Topics

Biotech Sage Company Profile

20:59 EST 15th December 2018 | BioPortfolio

BioTech Sage Report is newsletter that is published monthly. Our report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While our email updates focuses on news events, scientific advancements or biotechnology opportunities.

Our goal is to provide valuable information to assist you in your investment strategies. The aim of BioTech Sage Report is to keep our subscribers abreast of the ever changing and advancing field of biotechnology, with the basic belief that an informed investor is a successful stock investor.



We will discuss recent discoveries, their commercial implications and what developments wait. Each issue examines the biotech companies or pharmaceuticals that is related to our topic of the month and we also cover specific companies that we feel have great long-term appreciation. The report is an information integrator that provides you a wealth of information and ideas

Location

United States of America


News Articles [1745 Associated News Articles listed on BioPortfolio]

Sage licenses out depression drug in Asia, adding to cash warchest

Inking a deal with Shionogi for rights to SAGE-217, the biotech will earn $90 million upfront just as it preps for a potential market launch of brexanolone. 

Shionogi, Sage to Partner on Developing Depression Drug in Three Asian Markets

Shionogi & Co. will partner with Sage Therapeutics to develop and commercialize Sage’s SAGE-217 to treat major depressive disorder (MDD) and other indications in Japan, Taiwan, and South Korea, ...

Shionogi, Sage to Partner on Developing Depression Drug in 3 Asian Markets

Shionogi & Co. will partner with Sage Therapeutics to develop and commercialize Sage’s SAGE-217 to treat major depressive disorder (MDD) and other indications in Japan, Taiwan and South Korea, t...

FDA Provides Expedited Path Forward For Sage’s Depression Treatment SAGE-217

Following a meeting with the U.S. Food and Drug Administration Sage Therapeutics is seeing the goal line for potential expedited approval of its major depressive disorder (MDD) and postpartum depressi...

Sage Speeds Ahead With Plans For a Short-Course Depression Drug

Sage Therapeutics has announced a potential fast path to approval for an experimental depression drug—as well as plans to treat patients with it for just two weeks until they feel relief, not ch...

Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meetin

Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced its expedited deve...

Sage, Shionogi to collaborate on MDD drug in three Asian countries

Sage Therapeutics and Shionogi & Co. have agreed to collaborate for the clinical development and commercialization of the former’s SAGE-217 for the treatment of major depressive disorder (MDD) and o...

Sage Therapeutics Announces Third Quarter 2018 Financial Results

Sage Therapeutics (NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today reported business highlights...

PubMed Articles [48 Associated PubMed Articles listed on BioPortfolio]

Nanodispersions Stabilized by β-Cyclodextrin Nanosponges: Application for Simultaneous Enhancement of Bioactivity and Stability of Sage Essential Oil.

The aim of the present work was to stabilize oil-in-water nanoemulsion containing sage (salvia officinalis) essential oil, for enhancing its physicochemical stability and enlarging its industrial appl...

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.

The Strategic Advisory Group of Experts (SAGE) on Immunization advises WHO on global policies for vaccines. In April, 2016, SAGE issued recommendations on the use of the first licenced dengue vaccine,...

Second-quarter biotech job picture.

Third-quarter biotech job picture.

Gates unveils biotech-within-a-charity.

Clinical Trials [51 Associated Clinical Trials listed on BioPortfolio]

Effects of Sage on Memory and Mental Performance in Alzheimer's Disease Patients

The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease. Study hypothesis: The administration...

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

This study will assess the pharmacodynamic effects of SAGE-217 in approximately 42 healthy adult subjects using an insomnia model.

A Study to Evaluate SAGE-217 in Patients With Parkinson's Disease of Moderate Severity

This study will assess the safety, tolerability, pharmacokinetics and efficacy of SAGE-217 in up to 30 subjects with Parkinson's Disease of Moderate Severity.

A Study to Evaluate SAGE-217 in Subjects With Essential Tremor

This study is a two-part, multicenter, Phase 2a study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of SAGE-217 in up to 80 adult subjects with essential tremor.

A Study to Evaluate SAGE-547 in Patients With Severe Postpartum Depression

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female subjects diagn...

Companies [953 Associated Companies listed on BioPortfolio]

SAGE Therapeutics, Inc.

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous syste...

Biotech Sage

BioTech Sage Report is newsletter that is published monthly. Our report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While ou...

Sage Science

Sage Science develops game-changing instrument products for life science research and diagnostic laboratories. Sage Science is privately held. For more information visit www.sages...

Sage Science, Inc.

Sage Science develops game-changing instrument products for life science research and diagnostic laboratories. Sage Science is privately held. For more information visit www.sages...

Sage Software Healthcare, LLC

For nearly 30 years, physicians have trusted Sage to deliver solutions that enable them to optimize their patients' experience while enhancing their bottom line. Sage Software Healthcare, LLC, provide...

More Information about "Biotech Sage" on BioPortfolio

We have published hundreds of Biotech Sage news stories on BioPortfolio along with dozens of Biotech Sage Clinical Trials and PubMed Articles about Biotech Sage for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotech Sage Companies in our database. You can also find out about relevant Biotech Sage Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record